Nevada Board of Pharmacy proposes adding dipentylone and seven fentanyl-related substances to Schedule I (NAC 453.510)

The Nevada State Board of Pharmacy issued a Notice of Hearing/Intent to act upon a regulation proposing amendments to NAC 453.510 (Schedule I) to add dipentylone and seven fentanyl-related substances to Nevada’s Schedule I list under the Uniform Controlled Substances Act framework. The notice schedules a public hearing (March 5, 2026). If adopted, these substances would become subject to Schedule I restrictions, affecting controlled substance compliance programs (e.g., prohibitions/controls on possession, handling, distribution, and associated enforcement exposure).